Foghorn Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -48.1% | +1,044.0% | +103.4% | -22.1% | -29.4% | -0.7% | -30.2% | |
| – | -58.2% | +1,029.3% | +141.0% | -23.5% | -31.7% | +3.9% | -34.6% | |
| – | -62.6% | +519.4% | +9.0% | -48.4% | +53.9% | -31.0% | +45.8% | |
| – | -62.6% | +1,140.0% | -16.9% | +124.1% | -32.3% | +4.1% | -34.8% | |
| – | – | – | +35,529.5% | -99.2% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +77.7% | +1,578.8% | -10.0% | -11.9% | – | – | – | |
| – | +34.0% | -0.9% | +286.5% | -4.3% | -10.3% | -9.3% | -7.0% | |
| – | +265.8% | +49.0% | +158.4% | +13.4% | +5.9% | +14.6% | -10.8% | |
| – | – | -27.8% | +75.7% | -14.6% | +42.7% | +6.4% | -89.8% | |
| – | +70.8% | +7.0% | +3.8% | +41.8% | +15.6% | -39.5% | +12.7% | |
| – | +55.9% | +79.3% | – | – | – | – | – | |
| – | – | – | -33.7% | -99.9% | -69,019.6% | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +87.6% | -0.1% | +1.0% | +11.9% | +0.9% | +30.8% | +14.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.